Scinai Immunotherapeutic

Scinai Immunotherapeutic is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative inflammation and immunology (I&I) biological products, primarily for the treatment of autoimmune and infectious diseases. With state-of-the-art biopharmaceutical product development and manufacturing facilities, as well as experienced leadership in the pharmaceutical industry, Scinai provides end-to-end boutique CDMO services while developing its own diversified and commercially viable product and platform pipelines, starting with an innovative nanobody VHH antibody (NanoAb) pipeline targeting diseases with significant unmet medical needs.